Amarapurkar DN, Amarapurkar AD, Patel ND, Agal S, Baigal R, Gupte P, Pramanik S

Idioma: Ingles.
Referencias bibliográficas: 23
Paginas: 30-33
Archivo PDF: 45.49 Kb.

FRAGMENTO

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Sanyal A. Nonalcoholic steatohepatitis. Indian J Gastroenterol 2001; 20(suppl): C64-C70.

2. Amarapurkar DN, Amarapurkar AD. Nonalcoholic steatohepatitis: Clincopathological profile. JAPI 2000; 48: 311-313.

3. Teli MR, James OFW, Burt AD, Bennett MK, Day CP. The natural history of non-alcoholic fatty liver: a follow of study. Hepatology 1995; 22: 1714-1719.

4. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16.

5. Caldwell SH, Oelsner DH, Iezzani JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669.

6. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-19.

7. Farrell GC. Non-alcoholic steatohepatitis: what is it and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003; 18: 124-38.

8. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of non-alcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286-1292.

9. Agarwal SR, Malhotra V, Sakhuja P, Sarin SK. Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol 2001; 20: 183-186.

10. Sanyal AJ. Nonalcoholic fatty liver disease in the Indian subcontinent: a medical consequence of globalization? Indian J Gastroenterol 2001; 20: 215-216.

11. Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Disease 1999; 19: 221-229.

12. Angulo Paul, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362.

13. Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc 2000; 75: 733-739.

14. Lee RG. Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. Hepatology 1995; 21: 1742-1743.

15. Garcia-Monzon C, Martin-Perez E, Iacono OL, Fernandez-Bermejo M, Majano PL, Apolinario A, Larranaga E, Moreno-Otero R. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 2000; 33: 716- 724.

16. Harrison SA, Kadakia S, Lang KA, and Schenker S. Nonalcoholic steatohepatitis: what we know in the next millennium. Am J Gasteroenterol 2002; 97: 2714-2724.

17. Ramchandran A. Epidemiology of type 2 diabetes in Indians. J Indian Med Asso 2002; 100: 425-427.

18. Paulose KP. Risk factors in NIDDM. J Assoc Physicians India 1998; 46: 402.

19. Nanji AA, French SW, Freeman JB. Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients. Enzymes 1986; 36: 266-269.

20. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterol 1999; 116: 1413-1419.

21. Sorbi D, McGill DB, Thistle JL, Therneau TM, Henry J, Lindor KD. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am J Gastroenterol 2000; 95: 3206-3210.

22. Mofrad PS, Sanyal AJ. Nonalcoholic fatty liver disease, Medscape General medicine 2003; 5(2).

23. Shimada M, Hashimoto E, Kaneda H, Noguchi S, Hayashi N. Nonalcoholic steatohepatitis: risk factors for liver fibrosis. Hepatol Res 2002; 24: 429-438.